Laura M. Vos

559 total citations
20 papers, 351 citations indexed

About

Laura M. Vos is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, Laura M. Vos has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Surgery and 3 papers in Infectious Diseases. Recurrent topics in Laura M. Vos's work include Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (5 papers) and Influenza Virus Research Studies (4 papers). Laura M. Vos is often cited by papers focused on Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (5 papers) and Influenza Virus Research Studies (4 papers). Laura M. Vos collaborates with scholars based in Netherlands, Slovenia and Belgium. Laura M. Vos's co-authors include Jan Jelrik Oosterheert, Andy I. M. Hoepelman, Annelies Riezebos‐Brilman, Rob Schuurman, Andrea H. L. Bruning, Johannes B. Reitsma, Rienk Nieuwland, Arnoud W. Kastelein, Cornelis J.F. Van Noorden and Christianne Lok and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Laura M. Vos

18 papers receiving 343 citations

Peers

Countries citing papers authored by Laura M. Vos

Since Specialization

Citations

This map shows the geographic impact of Laura M. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura M. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura M. Vos more than expected).

Fields of papers citing papers by Laura M. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura M. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura M. Vos. The network helps show where Laura M. Vos may publish in the future.

Co-authorship network of co-authors of Laura M. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Laura M. Vos. A scholar is included among the top collaborators of Laura M. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura M. Vos. Laura M. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disseminated histoplasmosis induced hemophagocytic lymphohistiocytosis in an immunocompromised patient 2025 ·Clinical Infection in Practice ·(unknown), Laura M. Vos, Helen L. Leavis, Margot Jak, Anke H. W. Bruns, Maarten Limper	0
2	Solitary ovarian cancer cells in the peritoneum: What happens below the surface? 2022 ·SHILAP Revista de lepidopterología ·Laura M. Vos, Willemien J. van Driel, Gabe S. Sonke, (unknown), Koen Van de Vijver, Cornelis J.F. Van Noorden, Christianne Lok	0
3	Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer 2021 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·Laura M. Vos, S. Lot Aronson, Willemien J. van Driel, Alwin D. R. Huitema, Jules H. Schagen van Leeuwen, (unknown), Gabe S. Sonke	13
4	Lower respiratory tract infection in the community: associations between viral aetiology and illness course 2020 ·Clinical Microbiology and Infection ·Laura M. Vos, Robin Bruyndonckx, Nicolaas P. A. Zuithoff, Paul Little, Jan Jelrik Oosterheert, Berna DL Broekhuizen, Christine Lammens, Katherine Loens, Marco C. Viveen, Christopher Butler, Derrick W. Crook, Kalina T. Zlateva, Herman Goossens, Eric C. J. Claas, Margareta Ieven, Anton M. van Loon, Theo Verheij, Frank E. J. Coenjaerts	40
5	Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer 2020 ·Clinical & Experimental Metastasis ·Arnoud W. Kastelein, Laura M. Vos, (unknown), Jasper J. Koning, Vashendriya V.V. Hira, Rienk Nieuwland, Willemien J. van Driel, Zühre Uz, Thomas M. van Gulik, Jacco van Rheenen, Can İnce, Jan‐Paul Roovers, Cornelis J.F. Van Noorden, Christianne Lok	22
6	Inappropriate laboratory testing in internal medicine inpatients: Prevalence, causes and interventions 2020 ·Annals of Medicine and Surgery ·(unknown), Christiana A. Naaktgeboren, Laura M. Vos, Wouter W. van Solinge, H. A. H. Kaasjager, Maarten J. ten Berg	28
7	High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands 2019 ·Journal of Clinical Virology ·Laura M. Vos, Jan Jelrik Oosterheert, (unknown), Marco C. Viveen, Louis Bont, Andy I. M. Hoepelman, Frank E. J. Coenjaerts	16
8	More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients 2019 ·Journal of Clinical Virology ·Laura M. Vos, Jesper M. Weehuizen, Andy I. M. Hoepelman, Karin Kaasjager, Annelies Riezebos‐Brilman, Jan Jelrik Oosterheert	11
9	Testing for viral infections in severe lower respiratory tract infections; the unpredictable effects of diagnostic certainty 2019 ·Clinical Microbiology and Infection ·Laura M. Vos, Jan Jelrik Oosterheert	3
10	Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017 2019 ·Eurosurveillance ·Laura M. Vos, Anne Teirlinck, José Eugenio Lozano Alonso, Tomás Vega, Gé Donker, Andy I. M. Hoepelman, Louis Bont, Jan Jelrik Oosterheert, Adam Meijer	19
11	Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies 2019 ·Clinical Infectious Diseases ·Laura M. Vos, Andrea H. L. Bruning, Johannes B. Reitsma, Rob Schuurman, Annelies Riezebos‐Brilman, Andy I. M. Hoepelman, Jan Jelrik Oosterheert	80
12	External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study 2019 ·Journal of Medical Virology ·Laura M. Vos, Jan Jelrik Oosterheert, Andy I. M. Hoepelman, Louis Bont, Frank E. J. Coenjaerts, Christiana A. Naaktgeboren	5
13	Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature 2018 ·Seminars in Cell and Developmental Biology ·Arnoud W. Kastelein, Laura M. Vos, Kees H. de Jong, (unknown), Rienk Nieuwland, Cornelis J.F. Van Noorden, Jan‐Paul W. R. Roovers, Christianne Lok	41
14	25 Physicians’ perceptions of inappropriate laboratory testing in clinically admitted patients 2018 ·Oral Presentations ·(unknown), (unknown), Christiana Naaktgeboren, Laura M. Vos, (unknown), Karin A. H. Kaasjager	1
15	Syndromic sample-to-result PCR testing for respiratory infections in adult patients. 2018 ·PubMed ·Laura M. Vos, Annelies Riezebos‐Brilman, Rob Schuurman, Andy I. M. Hoepelman, Jan Jelrik Oosterheert	5
16	Long-term outcome of transvenous pacemaker implantation in infants: a retrospective cohort study 2016 ·EP Europace ·Laura M. Vos, Janneke A.E. Kammeraad, Matthias W. Freund, (unknown), Johannes M. P. J. Breur	23
17	Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment 2015 ·Journal of Crohn s and Colitis ·Johannan F. Brandse, Laura M. Vos, Jeroen M. Jansen, (unknown), Cyriel Ponsioen, Gijs R. van den Brink, Geert D’Haens, Mark Löwenberg	35
18	High Frequency of Polymicrobial Infections After Surgical Resection of Malignant Bone and Soft Tissue Tumors: A Retrospective Cohort Study 2015 ·Infectious Diseases and Therapy ·Laura M. Vos, P Morand, David Biau, (unknown), (unknown), Julien Loubinoux, (unknown), Philippe Leclerc, Joop E. Arends, Philippe Anract, Dominique Salmon	6
19	P470 High infliximab trough levels are associated with impaired quality of life in IBD patients in clinical and biochemical remission on maintenance IFX therapy 2014 ·Journal of Crohn s and Colitis ·Mark Löwenberg, Johannan F. Brandse, Laura M. Vos, Cyriel Ponsioen, (unknown), Geert D’Haens	2
20	Su1371 High Infliximab Trough Levels Are Associated With Impaired Quality of Life in IBD Patients in Clinical and Biochemical Remission on Maintenance IFX Therapy 2014 ·Gastroenterology ·Mark Löwenberg, Johannan F. Brandse, Laura M. Vos, Cyriel Y. Ponsioen, Gijs R. van den Brink, Geert D’Haens	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact